Clinical Trials Browser

Phase 1 × raltitrexed × Tumor-Agnostic × Clear all

NCT00001341 2008-03-04

A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease

Phase 1 Completed

Neoplasms